Editor`s Picks

Pharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader market highs, many in the sector, including Pfizer have faced selling pressure. However, Pfizer's...

SJVN (NS:SJVN), a key player in India's power sector, reported weaker-than-expected financial results for the fourth quarter of FY24. The company's consolidated adjusted profit after tax (PAT) was...

Expectations for a Fed rate cut have strengthened somewhat. ECB is almost certain to cut interest rates this week and eyes will be on Lagarde. Meanwhile, the Japanese Finance Ministry report...

Gold and silver prices dip after strong gains, but bulls remain optimistic for a trend resumption. Key US data and central bank decisions this week could impact the dollar and influence precious...

The S&P 500 defied May's historical trends with a robust 4.8% gain. But market breadth concerns loom as fewer stocks participate in the rally, indicating potential bearish signals. Investors are...

Let's see how we can take advantage of the fact that the exposure of 6 stocks in the S&P 500 is 30% and in the Nasdaq is 40%. While June is historically not a good month for stocks, that could...

Borussia Dortmund's remarkable Champions League run has propelled its stock price up by 14% year-to-date. Despite a disappointing Bundesliga season, fans are thrilled as the team prepares to face...

June is expected to be another eventful month on Wall Street amid a trio of key market-moving events. Investor focus will be on the U.S. jobs report, CPI inflation data, and the Fed’s FOMC...